Related Experiment Video
Updated: Aug 16, 2026

Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
E2F-1 is a critical modulator of cellular senescence in human cancer
Chaehwa Park1, Inkyoung Lee, Won Ki Kang
1Cancer Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 135-710, Korea. cpark@smc.samsung.co.kr
Abstract:
Senescence limits cellular proliferation, and therefore might be a mechanism which could suppress the progression of cancer. Herein we show that E2F1, a transcription factor essential to a cell cycle progress and a main target of tumor suppressor Rb, is a critical barrier for the induction of senescence. Human cancer cells transfected with siE2F1 were shown to express replicative senescence markers, in addition to yielding positive results upon SA-beta-Gal staining. Consistent with the notion of the critical role in senescence of E2F1, cells which overexpressed E2F1 proved to be immune to the induction of senescence. Importantly, it appears that E2F1 depletion-induced cancer cell senescence is not reliant on the integrity of either Rb or p53. Our results provide a molecular explanation for the selectivity with which senescence induction occurs, and also provides insights into the possibility of using E2F1 as a therapeutic target in the treatment of cancer.
Insights
E2F1 acts as a barrier to cellular senescence, a process that can prevent cancer. Inhibiting E2F1 in cancer cells induces senescence, suggesting E2F1 as a potential cancer therapy target.
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Background:
- Cellular senescence limits proliferation and may suppress cancer progression.
- The transcription factor E2F1 is crucial for cell cycle progression and is a target of tumor suppressor Rb.
Purpose of the Study:
- To investigate the role of E2F1 in the induction of cellular senescence.
- To explore the potential of targeting E2F1 for cancer therapy.
Main Methods:
- Transfection of human cancer cells with small interfering RNA (siE2F1) to deplete E2F1.
- Assessment of replicative senescence markers and SA-beta-Gal staining.
- Overexpression of E2F1 in cancer cells to evaluate senescence induction.
Main Results:
- Depletion of E2F1 in human cancer cells induced replicative senescence markers and SA-beta-Gal activity.
- Cancer cells overexpressing E2F1 were resistant to senescence induction.
- E2F1 depletion-induced senescence was independent of Rb and p53 integrity.
Conclusions:
- E2F1 is a critical barrier to the induction of cellular senescence.
- E2F1 depletion can induce cancer cell senescence independently of Rb and p53.
- Targeting E2F1 may offer a novel therapeutic strategy for cancer treatment.
More Related Videos
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
07:39SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Related Concept Videos
Negative Regulator Molecules
Telomeres and Telomerase
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitogens and the Cell Cycle
Replicative Cell Senescence
Abnormal Proliferation